Serotonin-norepinephrine reuptake inhibitors

Results: 200



#Item
41Microsoft Word - Synopsis-THAI[removed]_06March07_ final.doc

Microsoft Word - Synopsis-THAI[removed]_06March07_ final.doc

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-12-04 15:20:35
421 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (Duloxetine Delayed-Relea

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (Duloxetine Delayed-Relea

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-12-02 12:32:07
43Ernest J Dole, PharmD, PhC, FASHP, BCPS, CDE Pain Consultation and Treatment Center Clinical Pharmacist & UNMHSC College of Pharmacy

Ernest J Dole, PharmD, PhC, FASHP, BCPS, CDE Pain Consultation and Treatment Center Clinical Pharmacist & UNMHSC College of Pharmacy

Add to Reading List

Source URL: www.nmhr.org

Language: English - Date: 2013-08-03 13:07:34
44Antidepressant Medications: U.S. Food and Drug Administration-Approved Indications and Dosages for Use in Adults The therapeutic dosing recommendations for antidepressant medications are based on U.S. Food and Drug Admin

Antidepressant Medications: U.S. Food and Drug Administration-Approved Indications and Dosages for Use in Adults The therapeutic dosing recommendations for antidepressant medications are based on U.S. Food and Drug Admin

Add to Reading List

Source URL: www.cms.gov

Language: English - Date: 2014-11-13 10:51:08
451 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (Duloxetine Delayed-Relea

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYMBALTA safely and effectively. See full prescribing information for CYMBALTA. CYMBALTA (Duloxetine Delayed-Relea

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-10-17 10:36:14
46IMPORTANT: PLEASE READ  PART III: CONSUMER INFORMATION TRINTELLIX TM Vortioxetine (as vortioxetine hydrobromide) 5, 10, 20 mg tablets

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION TRINTELLIX TM Vortioxetine (as vortioxetine hydrobromide) 5, 10, 20 mg tablets

Add to Reading List

Source URL: www.lundbeck.com

Language: English - Date: 2014-10-27 12:13:33
47Microsoft Word - TRINTELLIX_PM_22OCT2014_E

Microsoft Word - TRINTELLIX_PM_22OCT2014_E

Add to Reading List

Source URL: www.lundbeck.com

Language: English - Date: 2014-11-05 14:52:01
48Microsoft Word - Duloxetine medication information - May 2013.doc

Microsoft Word - Duloxetine medication information - May 2013.doc

Add to Reading List

Source URL: keltymentalhealth.ca

Language: English - Date: 2013-05-22 18:08:39
49The Voice of the Patient Report: Fibromyalgia

The Voice of the Patient Report: Fibromyalgia

Add to Reading List

Source URL: www.fda.gov

Language: English
50N21-427S043 Duloxetine Clinpharm BPCA

N21-427S043 Duloxetine Clinpharm BPCA

Add to Reading List

Source URL: www.fda.gov

Language: English